Experimental Method
Synthesis of crystalline CaF 2 :Yb 3+ ,Tm 3+ @mSiO 2 nanospheres
In a typical procedure, 0.2 g cetyltrimethylammonium bromide (CTAB, ≥99%, SigmaAldrich Inc.), 25 mL deionized water, 5 mL ethanol (99.9 vol%, Sinopharm Chemical, China), 50 μL of triethanolamine (TEA, Sinopharm Chemical Reagent) were mixed and stirred at 60 o C for 30 min. Subsequently, 2 mL tetraethylorthosilicate (TEOS, Sigma-Aldrich Inc., USA) was added into the mixture solution under stirring until white precipitate forms. The precipitate was collected via centrifuging and calcined at 550 o C for 5 hours to remove organic additives. Three ethanol/TEOS volume ratios (2.5, 4, and 5) were set during the synthesis to control the particles size, denoted as MSNs-2.5, MSNs-4, MSNs-5, respectively. water, and then 6 ml trifluoroacetic acid (TFA, 99%，Sigma-Aldrich Inc.) was added dropwise into the mixed ionic solution under stirring for 24 hours at 40 o C. 400 mg MSN nanoparticles (MSNs-2.5, MSNs-4, MSNs-5) were added into 20 mL of the asprepared solution and immersed for 24 hours under stirring at 40 o C. Subsequently, all three samples were dried at 80 o C for 3 hours, and calcined in air at 600 o C for 3 hours to obtain the composite upconversion nanoparticles labeled as UCNP-2.5, UCNP-4, and UCNP-5.
In vitro cytotoxicity assay
To determine the cytotoxicity of UCNPs, the Cell Counting Kit-8 (CCK-8; Dojindo, Kamimashiki-gun Kumamoto, Japan) was performed. Briefly, cells (HEK 293 cells) were seeded into 96-well plates and cultured in a 5% CO 2 incubator (Heraeus, Hanau, Germany) for 12 hours. Then, the medium was removed and replaced with fresh medium containing varied concentrations of UCNPs. Subsequently, the 96-well plates were placed in the 5% CO 2 incubator for further 24 hours. To access the cytotoxicity, 100 µL fresh medium mixed with 10 µL CCK-8 solution was added to each well for 2 hours at 37 ºC. Then, the absorbance was then measured at 450 nm using an universal microplate reader (BIO-TEK Instruments, Minneapolis, MN, USA) Drug loading and release Doxorubicin (DOX), an anticancer drug, was used as a model drug. The DOX loading and releasing characteristics were examined following a reported method. 34 UCNP-2.5, UCNP-4, and UCNP-5 samples (50 mg) were added into DOX aqueous solution (1mg/mL, 20 mL) at ambient temperature. The mixture was subsequently stirred in the dark condition for 24 hours to achieve the equilibrium state. The DOX loaded samples were collected by centrifugation and washed with deionized water to remove the adsorbed DOX at the outer surface. The loading amount of drug was determined using UV-Vis spectral analysis and calculated following the equation, Drug loading efficiency = (weight of DOX loaded)/(weight of total DOX used)×100%
The in vitro DOX releasing test was performed by immersing the DOX loaded UCNPs in 20 mL of PBS under gentle stirring at 37 ± 0.1 °C. At predetermined time intervals, a 10 mL buffer solution was collected and immediately replaced with an equal volume of fresh PBS. The amount of released DOX in PBS solution was measured using an UV−vis spectrophotometer (TU-1810, China) at a maximum wavelength (λ max ) of 480 nm. Three measurements were performed for each sample .
In vitro cell viability during drug releasing
Cell proliferation during DOX releasing was assessed by the Cell Counting Kit-8 (CCK-8; Dojindo, Kamimashiki-gun Kumamoto, Japan) according to the manufacturer's instruction. Briefly, 6 × 10 3 cells (MCF-7 human breast cancer cells) were seeded onto 96-well plate and treated with free DOX, UCNP-2.5-DOX, UCNP-4-DOX and UCNP-5-DOX. 100 μL of CCK-8 solution was added into each chamber and incubated at 37 o C for 2 hours. Then, cell proliferation was assessed by measuring the absorbance at 450 nm using an universal microplate reader (BIO-TEK Instruments, Minneapolis, MN, USA).
MCF-7 cancer cells were seeded onto 8-chamber cell culture slide (Thermo Fisher Scientific Inc., Waltham, MA, USA) at 2 × 10 4 cells/chamber and incubated with UCNP-2.5-DOX, UCNP-4-DOX, and UCNP-5-DOX samples for 4 hours. The cells were fixed in 4 % paraformaldehyde for 15 minutes. After washing with 6.7mM phosphate-buffered saline (PBS, pH 7.4, HyClone Laboratories Inc., Logan, Utah), MCF-7 human breast cancer cells were stained with 4', 6-diamidino-2-phenylindole dihydrochloride (DAPI; Sigma-Aldrich Co., St. Louis, MO, USA) for 10 minutes. The cell morphology after culturing was examined using a laser scanning confocal microscopy (LSCM, Fluoview OLYMPUS, JAPAN CO., LTD, Tokyo, Japan).
Characterization
The morphology and microstructures of the samples were characterized by fieldemission scanning electron microscopy (FESEM, Hitachi SU-70, Japan) and highresolution transmission electron microscopy (HRTEM, Tecnai F20, FEI, USA). The crystal structure was examined using an X-ray diffraction instrument (XRD, X'Pert PRO MPD, The Netherlands) operating at 40 mA and 40 kV using Cu Kα radiation. The FTIR spectra were recorded on a PerkinElmer 580B infrared spectrophotometer on KBr pellets (Tensor 27, Bruker, Germany). The upconversion photoluminescence spectra were recorded at room temperature under the excitation of continuous laser with a wavelength of 980 nm from a fluorescence spectrophotometer (PL, FLSP920, Edinburgh). To minimize experimental uncertainties in the measurement, the sample positions and the spectra collection were maintained in identical conditions. 
